Access cutting-edge primary open angle glaucoma treatment through this clinical trial at a research site in Largo. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Largo location
Preparing your pre-screening questions…
Access primary open angle glaucoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related primary open angle glaucoma treatment provided free
Check if you qualify for this primary open angle glaucoma clinical trial in Largo, FL
No-Cost Study Care
Local to Largo
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a prospective, single arm, open label study conducted at a single site to evaluate the efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in reducing medication burden in patients with medically controlled ocular hypertension or primary open angle glaucoma. The study will assess the primary endpoint of reduction in medication count at 6 months compared to baseline. Secondary endpoints include IOP reduction compared to baseline (both percentage and absolute), complete success rate (no increase in IOP without medications), proportion of eyes needing medication at 6 months, and any secondary surgical interventions at 6 months post-DSLT. Participants will undergo DSLT with 120 shots, 400 µm spot size, and 1.8mJ fixed energy delivered at the limbus over 2.4 seconds. Follow-up visits will occur at 1 month, 3 months, and 6 months post-procedure, with IOP measured using a calibrated Goldmann tonometer.
Sponsor: The Eye Institute of West Florida
Yes, this clinical trial (NCT07390890) has an active research site in Largo, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for primary open angle glaucoma treatment options in Largo, FL, this clinical trial (NCT07390890) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Largo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary open angle glaucoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all primary open angle glaucoma clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Largo — not just this study.
Browse Pulmonary Embolism Trials in Largo →